$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Oct 23, 2025)
$562.12M
Market Cap
-
P/E Ratio
-1.97
EPS
$13.51
52 Week High
$2.86
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Olema Pharmaceuticals, Inc. is an emerging clinical-stage biopharmaceutical company headquartered in San Francisco, California, specializing in the development of targeted therapies for women's cancers. With a commitment to addressing substantial unmet medical needs in a historically underrepresented patient demographic, Olema is advancing an innovative pipeline of novel compounds aimed at improving patient outcomes. The company is strategically positioned within the oncology sector as it progresses through pivotal clinical trials, leveraging its scientific expertise to potentially redefine standard care practices in women's health. As Olema continues to evolve, it remains dedicated to delivering impactful solutions that could transform treatment paradigms in this critical area of medicine.
YYAI
BYND
SCNX
F
CGBS
VHAI
RGTI
AIRE
RIG
TSLA
INTC
VTYX
NOK
QBTS
NVDA
T
ADAP
MSAI
AAL
BITF
AREB
DNN
IONQ
PLUG
SMCI
TLRY
VZ
GRAB
SOFI
JOBY
RF
WGRX
CAN
QS
AMD
VLY
PLTR
LAES
RXRX
CIFR
PFE
UUUU
BTBT
MARA
AMC
DVLT
WBD
IREN
HPE
PBR
NIO
KMI
NVTS
SOUN
LUV
RR
SCWO
SNAP
BAC
APLD
HOOD
DNUT
LUMN
VALE
NCLH
ERIC
CLSK
KDLY
YYAI
BYND
SCNX
F
CGBS
VHAI
RGTI
AIRE
RIG
TSLA
INTC
VTYX
NOK
QBTS
NVDA
T
ADAP
MSAI
AAL
BITF
AREB
DNN
IONQ
PLUG
SMCI
TLRY
VZ
GRAB
SOFI
JOBY
RF
WGRX
CAN
QS
AMD
VLY
PLTR
LAES
RXRX
CIFR
PFE
UUUU
BTBT
MARA
AMC
DVLT
WBD
IREN
HPE
PBR
NIO
KMI
NVTS
SOUN
LUV
RR
SCWO
SNAP
BAC
APLD
HOOD
DNUT
LUMN
VALE
NCLH
ERIC
CLSK
KDLY